Cargando…
Hematologic side effects of biologics and kinase inhibitors used in rheumatologic diseases: a review of the current evidence
Treatment options for various rheumatologic diseases have been limited until the introduction of biologic agents and kinase inhibitor therapy in recent decades. Since their arrival, they have steadily been integrated into routine management. Given their wide use and overall successful outcomes, it b...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9243812/ https://www.ncbi.nlm.nih.gov/pubmed/35759025 http://dx.doi.org/10.1007/s00277-022-04896-7 |